LicianPro

Pharming Group NV

AAPL vs MSFT

Pharming Group NV (PHAR) SEC filings

Pharming Group NV (PHAR) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported PHAR revenue for 2025-12-31 was $376.1M. Net income was $2.9M. Revenue was up 26.6% from 2024-12-31 to 2025-12-31. PHAR currently screens at market cap $723.6M. The PHAR filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Pharming Group NV said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for PHAR — what management said, what changed, and why it matters.

No cached SEC filings for PHAR yet. When an 8-K lands, this page will list it.

These filings as JSON? API free 100/day

PHAR SEC filings FAQ

What events are listed on the PHAR SEC page?

Cached event headlines on this Pharming Group NV (PHAR) SEC page: "PHAR earnings". Events: https://lician.com/sec/phar

What are PHAR's latest revenue and net income?

Latest cached Pharming Group NV (PHAR) revenue for Dec 31, 2025 was $376.1M. Net income was $2.9M.